hydrazine has been researched along with Dyskinesia Syndromes in 43 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 43 (100.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| RAINE, AC; THOMAS, SF | 1 |
| Dill, RE; Dorris, RL; Furgeson, MD | 1 |
| Birket-Smith, E; Dupont, E; Hansen, E; Hyyppä, M; Marttila, R; Mikkelsen, B; Pakkenberg, H; Presthus, J; Rinne, UK | 1 |
| Koe, BK | 1 |
| Anders, TF; Barchas, JD; Berger, PA; Cann, HM; Ciaranello, RD | 1 |
| Adamkov, J; Drobný, M; Fundárek, J; Svaleková, A | 1 |
| Hayek, J | 1 |
| Barbeau, A; Roy, M | 1 |
| Gabreëls, FJ; Joosten, EM; Keyser, A; Korten, JJ | 1 |
| Goodgold, A; Jonas, S; Leibowitz, M; Lieberman, A | 1 |
| Birket-Smith, E | 1 |
| Kishikawa, H; Ohmoto, T | 1 |
| Csanda, E; Takáts, A; Tárczy, M | 1 |
| Aymard, N; Holzer, J; Rondot, P; Ziegler, M | 1 |
| Marion, MH; Marsden, CD; Quinn, NP | 1 |
| Ludin, HP | 1 |
| D'Andrea, G; Durisotti, C; Ferro-Milone, F; Lion, P; Lorizio, A; Nordera, GP | 1 |
| Baas, H; Fischer, PA | 1 |
| Lees, AJ; Poewe, WH; Stern, GM | 1 |
| Heersema, T; Jansen, EN; Meerwaldt, JD; Speelman, JD; van Manen, J | 1 |
| Jansen, EN; Meerwaldt, JD | 1 |
| Rinne, UK | 2 |
| Lees, AJ | 1 |
| Aljanati, R; Caamano, JL; Chouza, C; de Medina, O; Gonzales Panizza, V; Romero, S; Scarmelli, A | 1 |
| Dupont, E; Hansen, E; Jensen, NO; Mikkelsen, B; Mikkelsen, BO | 1 |
| Siegfried, J | 1 |
| Birkmayer, W; Neumayer, E | 1 |
| Mones, RJ; Pasik, P; Pasik, T; Wilk, S | 1 |
| Birkmayer, W | 1 |
| Birkmayer, W; Linauer, W; Mentasti, M; Riederer, P | 1 |
| Glasgow, GL; Henley, JW; Willoughby, EW | 1 |
| Cotzias, GC; Mena, I; Papavasiliou, PS | 1 |
| Dupont, E; Hansen, E; Holm, P; Melsens, S; Parkenberg, H | 1 |
| Allen, JG; Calne, DB; Davies, CA; Reid, JL; Vakil, SD | 1 |
| Andrews, CJ; Somerville, B | 1 |
| de Ajuriaguerra, J; Tissot, R | 1 |
| Fischer, PA; Jacobi, P; Maxion, H; Schneider, E | 1 |
| Fahn, S | 1 |
| Barbeau, A; Botez, MI; Joubert, M; Mars, H | 1 |
| Boggan, WO; Seiden, LS | 1 |
| Barbeau, A; Gillo-Joffroy, L; Mars, H | 1 |
2 review(s) available for hydrazine and Dyskinesia Syndromes
| Article | Year |
|---|---|
[Modern treatment of parkinsonism].
Topics: Antiparkinson Agents; Brain Stem; Dihydroxyphenylalanine; Dopamine; Drug Synergism; Female; Gastrointestinal Diseases; Humans; Hydrazines; Hydroxyindoleacetic Acid; Male; Movement Disorders; Norepinephrine; Parkinson Disease; Psychoses, Substance-Induced; Serotonin; Tryptophan | 1972 |
Recent advances in the treatment of Parkinsonism with drugs.
Topics: Amantadine; Animals; Aromatic Amino Acid Decarboxylase Inhibitors; Arrhythmias, Cardiac; Blood-Brain Barrier; Brain; Central Nervous System; Dihydroxyphenylalanine; Dopamine; Drug Interactions; Drug Tolerance; Humans; Hydrazines; Mental Disorders; Movement Disorders; Nausea; Parasympatholytics; Parkinson Disease; Rats; Time Factors; Vomiting | 1972 |
15 trial(s) available for hydrazine and Dyskinesia Syndromes
| Article | Year |
|---|---|
Levodopa alone and in combination with a peripheral decarboxylase inhibitor benserazide (Madopar) in the treatment of Parkinson's disease: A controlled clinical trial.
Topics: Adult; Aged; Aromatic Amino Acid Decarboxylase Inhibitors; Benserazide; Blood Pressure; Clinical Trials as Topic; Drug Therapy, Combination; Female; Humans; Hydrazines; Levodopa; Male; Middle Aged; Movement Disorders; Nausea; Parkinson Disease; Vomiting | 1975 |
Madopar versus sinemet. A clinical study on their effectiveness.
Topics: Adult; Aged; Benserazide; Carbidopa; Clinical Trials as Topic; Drug Evaluation; Female; Humans; Hydrazines; Levodopa; Male; Middle Aged; Movement Disorders; Parkinson Disease; Serine | 1975 |
Comparison of dopa decarboxylase inhibitor (carbidopa) combined with levodopa and levodopa alone in Parkinson's disease.
Topics: Adult; Aged; Carbidopa; Clinical Trials as Topic; Drug Combinations; Female; Humans; Hydrazines; Levodopa; Male; Mental Disorders; Middle Aged; Movement Disorders; Parkinson Disease | 1975 |
Clinical trial of Madopar HBS in parkinsonian patients with fluctuating drug response after long-term levodopa therapy.
Topics: Aged; Benserazide; Clinical Trials as Topic; Delayed-Action Preparations; Drug Combinations; Female; Humans; Hydrazines; Levodopa; Male; Middle Aged; Movement Disorders; Parkinson Disease; Time Factors | 1987 |
Open study of Madopar HBS, a new formulation of levodopa with benserazide, in 13 patients with Parkinson's disease and 'on-off' fluctuations.
Topics: Adult; Aged; Benserazide; Clinical Trials as Topic; Delayed-Action Preparations; Dose-Response Relationship, Drug; Drug Combinations; Female; Humans; Hydrazines; Levodopa; Male; Middle Aged; Movement Disorders; Parkinson Disease | 1987 |
Open clinical study of Madopar HBS.
Topics: Adult; Aged; Benserazide; Clinical Trials as Topic; Delayed-Action Preparations; Dose-Response Relationship, Drug; Drug Combinations; Female; Humans; Hydrazines; Infant, Newborn; Levodopa; Male; Middle Aged; Movement Disorders; Parkinson Disease | 1987 |
Treatment of parkinsonian conditions with a controlled-release form of levodopa--preliminary study.
Topics: Adult; Aged; Benserazide; Clinical Trials as Topic; Delayed-Action Preparations; Dose-Response Relationship, Drug; Drug Combinations; Female; Humans; Hydrazines; Levodopa; Male; Middle Aged; Movement Disorders; Parkinson Disease | 1987 |
Preliminary experience with Madopar HBS: clinical observations and plasma levodopa concentrations.
Topics: Adult; Aged; Benserazide; Clinical Trials as Topic; Delayed-Action Preparations; Drug Combinations; Female; Follow-Up Studies; Humans; Hydrazines; Levodopa; Male; Middle Aged; Movement Disorders; Parkinson Disease | 1987 |
Clinical and pharmacokinetic observations with Madopar HBS in hospitalized patients with Parkinson's disease and motor fluctuations.
Topics: Benserazide; Clinical Trials as Topic; Delayed-Action Preparations; Dose-Response Relationship, Drug; Drug Combinations; Female; Hospitalization; Humans; Hydrazines; Levodopa; Male; Middle Aged; Movement Disorders; Parkinson Disease | 1987 |
Open multicenter trial with Madopar HBS in parkinsonian patients. Preliminary assessment after short-term treatment.
Topics: Aged; Benserazide; Clinical Trials as Topic; Delayed-Action Preparations; Dose-Response Relationship, Drug; Drug Combinations; Female; Humans; Hydrazines; Levodopa; Male; Middle Aged; Movement Disorders; Parkinson Disease; Time Factors | 1987 |
[10 years of L-DOPA therapy of Parkinson's syndrome].
Topics: Administration, Oral; Amphetamine; Animals; Brain Chemistry; Catecholamines; Clinical Trials as Topic; Cognition Disorders; Constipation; Dihydroxyphenylalanine; Dopamine; Drug Synergism; Feeding and Eating Disorders; Hallucinations; Humans; Huntington Disease; Hydrazines; Hypertension; Infusions, Parenteral; Injections, Intravenous; Monoamine Oxidase Inhibitors; Movement Disorders; Nausea; Norepinephrine; Parkinson Disease; Serotonin; Stimulation, Chemical; Time Factors; Tremor; Vomiting | 1971 |
[2-year experiences with a combination treatment of Parkinsonism with L-dopa and a decarboxylase inhibitor (Benserazid, Ro 4-4602)].
Topics: Benserazide; Carboxy-Lyases; Clinical Trials as Topic; Dermatitis, Seborrheic; Dihydroxyphenylalanine; Drug Combinations; Drug Evaluation; Humans; Hydrazines; Movement Disorders; Muscle Rigidity; Parkinson Disease; Speech Disorders; Tremor | 1974 |
L-alpha-methyldopa hydrazine (Carbidopa) combined with L-dopa in the treatment of Parkinson's disease.
Topics: Aged; Blood Pressure; Carbidopa; Clinical Trials as Topic; Depression, Chemical; Drug Eruptions; Drug Therapy, Combination; Female; Humans; Hydrazines; Levodopa; Male; Middle Aged; Movement Disorders; Nausea; Parkinson Disease; Placebos; Posture; Vomiting | 1974 |
Plasma concentration of levodopa in Parkinsonism before and after inhibition of peripheral decarboxylase.
Topics: Carboxy-Lyases; Clinical Trials as Topic; Dihydroxyphenylalanine; Humans; Hydrazines; Male; Methyldopa; Movement Disorders; Parkinson Disease | 1972 |
Levodopa combined with MK 486 (L-alpha methyldopahydrazine)--a peripheral decarboxylase inhibitor in Parkinson's disease.
Topics: Adult; Aged; Carbidopa; Carboxy-Lyases; Clinical Trials as Topic; Dihydroxyphenylalanine; Drug Therapy, Combination; Female; Humans; Hydrazines; Male; Middle Aged; Movement Disorders; Nausea; Parkinson Disease; Placebos | 1974 |
26 other study(ies) available for hydrazine and Dyskinesia Syndromes
| Article | Year |
|---|---|
Severe brain syndrome following phenelzine overdosage.
Topics: Antidepressive Agents; Brain; Brain Diseases; Drug Overdose; Humans; Hydrazines; Movement Disorders; Phenelzine | 1962 |
Importance of O-methylation in dopamine-induced motor and behavioral phenomena.
Topics: Animals; Behavior, Animal; Corpus Striatum; Dopamine; Drug Combinations; Humans; Hydrazines; Male; Methylation; Motor Activity; Movement Disorders; Rats; Reaction Time; Stereotyped Behavior; Tremor; Tropolone; Tyramine | 1976 |
Monoamine oxidase inhibitors antagonize the acceleration of brain dopamine synthesis induced by neuroleptic drugs in vivo: implications for the treatment of Tardive dyskinesia.
Topics: Animals; Brain; Corpus Striatum; Dopamine; Hydrazines; Male; Monoamine Oxidase Inhibitors; Movement Disorders; Pargyline; Rats; Tetrabenazine; Tranquilizing Agents; Trifluoperazine | 1975 |
Further observations on the use of 5-hydroxytryptophan in a child with Lesch-Nyhan syndrome.
Topics: 5-Hydroxytryptophan; Carbidopa; Child; Drug Therapy, Combination; Humans; Hydrazines; Lesch-Nyhan Syndrome; Male; Movement Disorders; Self Mutilation; Sleep; Wakefulness | 1978 |
[Therapy of rigidity and hypokinesis in old age using Sinemet].
Topics: Aged; Carbidopa; Drug Combinations; Female; Humans; Hydrazines; Levodopa; Male; Movement Disorders; Muscle Rigidity; Parkinson Disease, Postencephalitic; Trihexyphenidyl | 1979 |
[Treatment of Parkinson's disease with the combination drug L-carbidopa/L-dopa. Report on a 2 years study].
Topics: Carbidopa; Drug Combinations; Drug Evaluation; Female; Humans; Hydrazines; Levodopa; Male; Movement Disorders; Parkinson Disease; Psychoses, Substance-Induced | 1977 |
Six-year results of treatment with levodopa plus benzerazide in Parkinson's disease.
Topics: Adult; Aged; Benserazide; Drug Therapy, Combination; Female; Humans; Hydrazines; Levodopa; Male; Middle Aged; Movement Disorders; Parkinson Disease; Patient Dropouts; Time Factors | 1976 |
Abnormal involuntary movements in relation to anticholinergics and levodopa therapy.
Topics: Benserazide; Dose-Response Relationship, Drug; Drug Interactions; Drug Therapy, Combination; Humans; Hydrazines; Levodopa; Movement Disorders; Parasympatholytics; Parkinson Disease | 1975 |
L-dopa therapy combined with peripheral decarboxylase inhibitor (MK-486) in Parkinsonism.
Topics: Adult; Aged; Animals; Carbidopa; Carboxy-Lyases; Cats; Dopamine; Drug Therapy, Combination; Female; Humans; Hydrazines; Injections, Intraperitoneal; Levodopa; Male; Middle Aged; Movement Disorders; Parkinson Disease | 1975 |
(-)Deprenyl in the treatment of decompensated Parkinson's disease.
Topics: Benserazide; Drug Combinations; Humans; Hydrazines; Levodopa; Movement Disorders; Parkinson Disease; Phenethylamines; Selegiline | 1986 |
Madopar HBS in Parkinson patients with nocturnal akinesia.
Topics: Adult; Aged; Benserazide; Delayed-Action Preparations; Drug Combinations; Female; Humans; Hydrazines; Levodopa; Male; Middle Aged; Movement Disorders; Parkinson Disease; Time Factors | 1988 |
Madopar HBS in the long-term treatment of parkinsonian patients with fluctuations in disability.
Topics: Aged; Benserazide; Delayed-Action Preparations; Dose-Response Relationship, Drug; Drug Combinations; Female; Humans; Hydrazines; Levodopa; Male; Middle Aged; Movement Disorders; Parkinson Disease; Time Factors | 1987 |
A sustained-release formulation of L-dopa (Madopar HBS) in the treatment of nocturnal and early-morning disabilities in Parkinson's disease.
Topics: Benserazide; Circadian Rhythm; Delayed-Action Preparations; Drug Combinations; Female; Humans; Hydrazines; Levodopa; Male; Middle Aged; Movement Disorders; Parkinson Disease | 1987 |
Substitution of standard Madopar by Madopar HBS in parkinsonians with fluctuations.
Topics: Aged; Aged, 80 and over; Benserazide; Biological Availability; Delayed-Action Preparations; Dose-Response Relationship, Drug; Drug Combinations; Drug Tolerance; Female; Humans; Hydrazines; Levodopa; Male; Middle Aged; Movement Disorders; Parkinson Disease | 1987 |
Madopar HBS: slow-release levodopa and benserazide in parkinsonian patients presenting marked fluctuations in symptoms on standard L-dopa treatment.
Topics: Adult; Aged; Benserazide; Delayed-Action Preparations; Drug Combinations; Female; Humans; Hydrazines; Levodopa; Male; Middle Aged; Movement Disorders; Parkinson Disease | 1987 |
Therapeutic value of Madopar HBS: judgment after 2 years experience.
Topics: Adult; Aged; Aged, 80 and over; Benserazide; Delayed-Action Preparations; Dose-Response Relationship, Drug; Drug Combinations; Female; Follow-Up Studies; Humans; Hydrazines; Levodopa; Male; Middle Aged; Movement Disorders; Parkinson Disease | 1987 |
The modification of L-dopa induced dyskinesias in the monkey by unilateral nigral lesions.
Topics: Animals; Caudate Nucleus; Dihydroxyphenylalanine; Disease Models, Animal; Dopamine; Haplorhini; Hydrazines; Macaca; Movement Disorders; Substantia Nigra | 1973 |
Short- and long-term approaches to the "on-off" phenomenon.
Topics: Apomorphine; Carbidopa; Dietary Proteins; Drug Therapy, Combination; Humans; Hydrazines; Levodopa; Movement Disorders; Parkinson Disease; Time Factors | 1974 |
Treatment of Parkinsonism with a combination of levodopa and the decarboxylase inhibitor and RO 46-4602 (a comparison with levodopa treatment alone).
Topics: Administration, Oral; Aromatic Amino Acid Decarboxylase Inhibitors; Capsules; Dihydroxyphenylalanine; Dose-Response Relationship, Drug; Drug Combinations; Humans; Hydrazines; Movement Disorders; Nausea; Parkinson Disease; Retrospective Studies; Time Factors; Vomiting | 1972 |
[Parkinson's syndrome. 4 years of experience in treatment with L Dopa associated with a decarboxylase inhibitor. Clinical and biochemical study].
Topics: Benzyl Compounds; Carboxy-Lyases; Depression; Dihydroxyphenylalanine; Drug Combinations; Humans; Hydrazines; Movement Disorders; Parkinson Disease; Serotonin | 1973 |
[Comparison of the effect of L-Dopa and of an L-Dopa+decarboxylase inhibitor combination in Parkinson's disease].
Topics: Aged; Carboxy-Lyases; Dihydroxyphenylalanine; Drug Combinations; Drug Synergism; Female; Gastrointestinal Diseases; Humans; Hydrazines; Hypotension; Male; Middle Aged; Movement Disorders; Parkinson Disease; Time Factors | 1973 |
Levodopa and related drugs.
Topics: Amantadine; Apomorphine; Dihydroxyphenylalanine; Humans; Hydrazines; Hypotension; Mental Disorders; Movement Disorders; Nausea; Parasympatholytics; Parkinson Disease; Pyridoxine | 1973 |
"On-off" phenomenon with levodopa therapy in Parkinsonism. Clinical and pharmacologic correlations and the effect of intramuscular pyridoxine.
Topics: Adult; Carbidopa; Dihydroxyphenylalanine; Drug Synergism; Evaluation Studies as Topic; Female; Homovanillic Acid; Humans; Hydrazines; Injections, Intramuscular; Male; Methyldopa; Middle Aged; Movement Disorders; Parkinson Disease; Pyridoxine | 1974 |
Levodopa combined with peripheral decarboxylase inhibition in Parkinson's disease.
Topics: Adult; Aged; Aromatic Amino Acid Decarboxylase Inhibitors; Arrhythmias, Cardiac; Benzyl Compounds; Dihydroxyphenylalanine; Female; Humans; Hydrazines; Hypotension; Middle Aged; Movement Disorders; Parkinson Disease; Serine; Vertigo | 1972 |
Dopa reversal of reserpine enhancement of audiogenic seizure susceptibility in mice.
Topics: Animals; Behavior, Animal; Benzyl Compounds; Brain Chemistry; Dihydroxyphenylalanine; Dopa Decarboxylase; Dopamine; Hydrazines; Mice; Movement Disorders; Norepinephrine; Reserpine; Seizures; Serine; Sound | 1971 |
Adverse clinical side effects of levodopa therapy.
Topics: Antiparkinson Agents; Arrhythmias, Cardiac; Benserazide; Carboxy-Lyases; Dihydroxyphenylalanine; Edema; Endocrine System Diseases; Feeding and Eating Disorders; Hematopoiesis; Humans; Hydrazines; Libido; Movement Disorders; Myocardial Infarction; Nausea; Neurologic Manifestations; Respiration; Time Factors; Uric Acid; Urination Disorders; Vomiting | 1971 |